日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Evidence of Atezolizumab Efficacy as Part of First-Line Treatment for Extensive-Stage SCLC in Bulgaria

保加利亚阿特珠单抗一线治疗广泛期小细胞肺癌的真实世界疗效证据

Manova, Manoela; Ivanova, Boryana; Krasteva, Rositsa; Conev, Nikolay; Zlatanova, Tanya; Arabadjiev, Jeliazko; Chilingirova, Natalia; Petrova, Mila; Dudov, Assen; Robev, Bozhil; Minchev, Velko; Tonev, Ivan; Koynov, Krassimir; Penchev, Daniel; Georgiev, Todor; Rangelov, Antoan; Savova, Alexandra

Gastrointestinal Cancers with Consideration of DPD and UGT1A1 Plasma Levels: Chemotherapy-Related Toxicity

考虑DPD和UGT1A1血浆水平的胃肠道癌症:化疗相关毒性

Minchev, Velko; Tsankov, Hristo; Robev, Bozil; Takov, Martin; Federchev, Stefan; Kamenova, Kalina; Todorov, Lozan; Atanasova, Liliya; Hristova-Avakumova, Nadya; Nikolov, Rumen; Gateva, Pavlina; Mitev, Vanyo

Complementary Treatment of Breast Cancer Cells with Different Metastatic Potential with Iscador Qu in the Presence of Clinically Approved Anticancer Drugs

在临床批准的抗癌药物存在的情况下,使用伊斯卡多尔Qu对具有不同转移潜能的乳腺癌细胞进行辅助治疗

Iliev, Ivan; Tsoneva, Iana; Nesheva, Aleksandrina; Staneva, Galya; Robev, Bozhil; Momchilova, Albena; Nikolova, Biliana

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells

针对结直肠癌细胞中激活的 ADAM10 的全人源单克隆抗体

Nayanendu Saha, Du-San Baek, Rachelle P Mendoza, Dorothea Robev, Yan Xu, Yehuda Goldgur, M Jason De La Cruz, Elisa de Stanchina, Peter W Janes, Kai Xu, Dimiter S Dimitrov, Dimitar B Nikolov

Antitumor Effect of Iscador on Breast Cancer Cell Lines with Different Metastatic Potential

伊斯卡多对不同转移潜能的乳腺癌细胞系的抗肿瘤作用

Robev, Bozhil; Iliev, Ivan; Tsoneva, Iana; Momchilova, Albena; Nesheva, Alexandrina; Kostadinova, Aneliya; Staneva, Galya; Nikolova, Biliana

Impact of Truncated Oxidized Phosphatidylcholines on Phospholipase A2 Activity in Mono- and Polyunsaturated Biomimetic Vesicles

截短氧化磷脂酰胆碱对单不饱和和多不饱和仿生囊泡中磷脂酶 A2 活性的影响

Vesela Yordanova, Rusina Hazarosova, Victoria Vitkova, Albena Momchilova, Bozhil Robev, Biliana Nikolova, Plamen Krastev, Philippe Nuss, Miglena I Angelova, Galya Staneva

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells

针对癌细胞上表达的 ADAM17 的抑制性单克隆抗体

Nayanendu Saha, Kai Xu, Zhongyu Zhu, Dorothea Robev, Teja Kalidindi, Yan Xu, Juha Himanen, Elisa de Stanchina, Naga Vara Kishore Pillarsetty, Dimiter S Dimitrov, Dimitar B Nikolov

Effect of Quercetin and Fingolimod, Alone or in Combination, on the Sphingolipid Metabolism in HepG2 Cells

槲皮素和芬戈莫德单独或联合使用对 HepG2 细胞鞘脂代谢的影响

Albena Momchilova, Georgi Nikolaev, Stefan Pankov, Evgenia Vassileva, Nikolai Krastev, Bozhil Robev, Dimo Krastev, Adriana Pinkas, Roumen Pankov

Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells

白藜芦醇影响A549肺腺癌细胞鞘脂代谢

Albena Momchilova, Roumen Pankov, Galya Staneva, Stefan Pankov, Plamen Krastev, Evgenia Vassileva, Rusina Hazarosova, Nikolai Krastev, Bozhil Robev, Biliana Nikolova, Adriana Pinkas

The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism

Ephb2受体利用其胞外结构域内的同型头尾相互作用作为一种自身抑制控制机制。

Xu, Yan; Robev, Dorothea; Saha, Nayanendu; Wang, Bingcheng; Dalva, Matthew B; Xu, Kai; Himanen, Juha P; Nikolov, Dimitar B